First Time Loading...

Mirati Therapeutics Inc
NASDAQ:MRTX

Watchlist Manager
Mirati Therapeutics Inc Logo
Mirati Therapeutics Inc
NASDAQ:MRTX
Watchlist
Price: 58.7 USD Market Closed
Updated: Apr 29, 2024

Mirati Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mirati Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Mirati Therapeutics Inc
NASDAQ:MRTX
Cash from Investing Activities
$207.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
48%
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
-24%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is Mirati Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
207.8m USD

Based on the financial report for Sep 30, 2023, Mirati Therapeutics Inc's Cash from Investing Activities amounts to 207.8m USD.

What is Mirati Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
48%